These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 8912897)
1. Contributions of donor and host blood vessels in CNS allografts. Baker-Cairns BJ; Sloan DJ; Broadwell RD; Puklavec M; Charlton HM Exp Neurol; 1996 Nov; 142(1):36-46. PubMed ID: 8912897 [TBL] [Abstract][Full Text] [Related]
2. Allografts of CNS tissue possess a blood-brain barrier: III. Neuropathological, methodological, and immunological considerations. Broadwell RD; Baker BJ; Ebert PS; Hickey WF Microsc Res Tech; 1994 Apr; 27(6):471-94. PubMed ID: 8012052 [TBL] [Abstract][Full Text] [Related]
3. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor. Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898 [TBL] [Abstract][Full Text] [Related]
4. Angioarchitecture of the CNS, pituitary gland, and intracerebral grafts revealed with peroxidase cytochemistry. Broadwell RD; Charlton HM; Balin BJ; Salcman M J Comp Neurol; 1987 Jun; 260(1):47-62. PubMed ID: 3597834 [TBL] [Abstract][Full Text] [Related]
5. Allografts of CNS tissue possess a blood-brain barrier. II. Angiogenesis in solid tissue and cell suspension grafts. Broadwell RD; Charlton HM; Ebert PS; Hickey WF; Shirazi Y; Villegas J; Wolf AL Exp Neurol; 1991 Apr; 112(1):1-28. PubMed ID: 2013306 [TBL] [Abstract][Full Text] [Related]
6. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat. Brauer RB; Baldwin WM; Ibrahim S; Sanfilippo F Transplantation; 1995 Jan; 59(2):288-93. PubMed ID: 7839453 [TBL] [Abstract][Full Text] [Related]
7. Prolonged survival of rat hepatic allografts pretreated with a single donor-specific blood transfusion: the distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient. Yamaguchi Y; Goto M; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M J Surg Res; 1996 Feb; 61(1):23-9. PubMed ID: 8769937 [TBL] [Abstract][Full Text] [Related]
8. Cellular basis of allograft rejection in vivo. V. Examination of the mechanisms responsible for the differing efficacy of monoclonal antibody to CD4+ T cell subsets in low- and high-responder rat strains. Ilano AL; McConnell MV; Gurley KE; Spinelli A; Pearce NW; Hall BM J Immunol; 1989 Nov; 143(9):2828-36. PubMed ID: 2572644 [TBL] [Abstract][Full Text] [Related]
9. NGF and anti-transferrin receptor antibody conjugate: short and long-term effects on survival of cholinergic neurons in intraocular septal transplants. Granholm AC; Bäckman C; Bloom F; Ebendal T; Gerhardt GA; Hoffer B; Mackerlova L; Olson L; Söderström S; Walus LR J Pharmacol Exp Ther; 1994 Jan; 268(1):448-59. PubMed ID: 8301587 [TBL] [Abstract][Full Text] [Related]
10. Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts. Qian Z; Jakobs FM; Pfaff-Amesse T; Sanfilippo F; Baldwin WM J Heart Lung Transplant; 1998 May; 17(5):470-8. PubMed ID: 9628565 [TBL] [Abstract][Full Text] [Related]
11. Infiltrating CD45RC- T cells are associated with immunologic unresponsiveness induced by donor class I major histocompatibility complex antigens in rats. Yamaguchi Y; Miyanari N; Ichiguchi O; Akizuki E; Matsumura F; Matsuda T; Okabe K; Liang J; Ohshiro H; Mori K; Ogawa M Hepatology; 1998 Aug; 28(2):450-8. PubMed ID: 9696011 [TBL] [Abstract][Full Text] [Related]
12. BN rats do not reject F344 brain allografts even after systemic sensitization. Poltorak M; Freed WJ Ann Neurol; 1991 Apr; 29(4):377-88. PubMed ID: 1929209 [TBL] [Abstract][Full Text] [Related]
13. The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses. Wasowska B; Baldwin WM; Howell DN; Sanfilippo F Transplantation; 1993 Sep; 56(3):672-80. PubMed ID: 7692630 [TBL] [Abstract][Full Text] [Related]
14. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival. Wasowska B; Baldwin WM; Sanfilippo F Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737 [TBL] [Abstract][Full Text] [Related]
15. Single dose anti-CD4 monoclonal antibody for induction of tolerance to cardiac allograft in high- and low-responder rat strain combinations. Qi Z; Riesbeck K; Ostraat O; Tufveson G; Ekberg H Transpl Immunol; 1997 Sep; 5(3):204-11. PubMed ID: 9402687 [TBL] [Abstract][Full Text] [Related]
16. Contrasting outcomes of donor-specific blood transfusion: effectiveness against cell-mediated but not antibody-mediated rejection. Yang CP; Shittu E; McManus B; Wood PJ; Bell EB Transplantation; 1998 Sep; 66(5):639-45. PubMed ID: 9753346 [TBL] [Abstract][Full Text] [Related]
17. Certain host-donor strain combinations do not reject brain allografts after systemic sensitization. Isono M; Poltorak M; Kulaga H; Adams AJ; Freed WJ Exp Neurol; 1993 Jul; 122(1):48-56. PubMed ID: 8339789 [TBL] [Abstract][Full Text] [Related]